Literature DB >> 26907872

Editorial for Issue 1, Jan 2016 title of the editorial 2016 : A year for JCCS Editorial changes and CCN3 KO mice at ICCNS.

Bernard Perbal1,2.   

Abstract

The year 2016 will see significant improvements for the Journal of Cell Communication and Signaling with the earning of an official Impact Factor and the merger of Springer Science + Business Media and part of Macmillan Sciences and Education. It will also be an important year for the International CCN Society (ICCNS) with the nomination of a new Scientific Board and reinforcement of interactions with other major scientific societies interested in various aspects of Cell Signaling. Starting this year the ICCNS will become an official provider of CCN3 knock out mice to ICCNS members. This first step in opening up access to certified reagents as a service for our CCN scientific community is part of our intention and efforts to attain the highest degree of assistance and enabler of scientific cooperation and communication in Science Communication.

Entities:  

Year:  2016        PMID: 26907872      PMCID: PMC4850143          DOI: 10.1007/s12079-016-0318-x

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  3 in total

1.  It's a knockout: CCN3 suppresses neointimal thickening.

Authors:  Andrew Leask
Journal:  J Cell Commun Signal       Date:  2010-02-24       Impact factor: 5.782

2.  What kind of a life for a scientific journal?

Authors:  Bernard Perbal
Journal:  J Cell Commun Signal       Date:  2015-09-03       Impact factor: 5.782

3.  CCN3 inhibits neointimal hyperplasia through modulation of smooth muscle cell growth and migration.

Authors:  Tatsushi Shimoyama; Shûichi Hiraoka; Minoru Takemoto; Masaya Koshizaka; Hirotake Tokuyama; Takahiko Tokuyama; Aki Watanabe; Masaki Fujimoto; Harukiyo Kawamura; Seiya Sato; Yuya Tsurutani; Yasushi Saito; Bernard Perbal; Haruhiko Koseki; Koutaro Yokote
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-05       Impact factor: 8.311

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.